Position in EDIT
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$121,966
+$58,285 QoQ
Shares Held
37,644
+46.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 216 holders
Holding Since
Dec 2020
6 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $303,308,584 across 140 Biotechnology names. EDIT ranks #104 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
941,283 | $124,936,492 | |
| 2 | CAPR |
Capricor Therapeutics, Inc.
|
802,732 | $19,329,786 | |
| 3 | ORMP |
Oramed Pharmaceuticals Inc.
|
3,810,540 | $18,328,697 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,705 | $15,252,094 | |
| 5 | INCY |
Incyte Corp
|
116,207 | $13,173,225 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,126 | $12,549,366 | |
| 7 | EXEL |
Exelixis, Inc.
|
176,339 | $9,594,604 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
102,823 | $8,940,459 |
All Filings in EDIT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,966 | 37,644 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $63,681 | 25,782 | Shares | Sole | 2026-05-15 | |
| 2023-09-30 | $183,892 | 23,576 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $166,492 | 20,230 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $113,382 | 15,639 | Shares | Sole | 2023-05-16 | |
| 2020-12-31 | $255,480 | 3,644 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||